BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ignite II - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ignite II
X-ORIGINAL-URL:https://gmkb.org
X-WR-CALDESC:Events for Ignite II
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240329
DTSTAMP:20260423T175443
CREATED:20231231T202746Z
LAST-MODIFIED:20231231T202746Z
UID:3807-1711411200-1711670399@gmkb.org
SUMMARY:2024 Precision Medicine Tri-Conference
DESCRIPTION:2024 Precision Medicine Tri-Conference \nMarch 26-28 | San Diego\, CA \nJoin thousands of international thought leaders to discuss the latest research\, technologies\, innovation and business models in precision medicine and precision health. Topics will include innovation and market access strategies for at-home diagnostics\, liquid biopsy and advanced diagnostics for precision oncology\, AI and digital tools\, spatial biology and single-cell multiomics in advancing precision medicine and more. \nTo learn more and register\, visit the conference website. \nPlease note: Registration is required for both in-person and virtual attendees.
URL:https://gmkb.org/event/2024-precision-medicine-tri-conference/
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240322T120000
DTEND;TZID=America/New_York:20240322T130000
DTSTAMP:20260423T175443
CREATED:20240229T215532Z
LAST-MODIFIED:20240229T215532Z
UID:3902-1711108800-1711112400@gmkb.org
SUMMARY:Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative
DESCRIPTION:Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative \nFriday\, March 22 | 12 p.m. ET | Hybrid: 321 MacNider Hall & Virtual \nSpeaker: Vardit Ravitsky\, PhD\nPresident and CEO\, The Hastings Center\nSenior Lecturer on Global Health and Social Medicine\, Harvard Medical School\nProfessor\, University of Montréal \nDr. Ravitsky will be speaking at the UNC Center for Bioethics’ Research Ethics Grand Rounds Merrimon Lecture. She is the President and CEO of The Hastings Center\, an independent\, nonpartisan bioethics research institute that is among the most prestigious bioethics and health policy institutes in the world. Dr. Ravitsky joins the Center from the University of Montreal where she was Professor at the Bioethics Program\, School of Public Health. She is also a Senior Lecturer on Global Health and Social Medicine at Harvard Medical School. She received her PhD from Bar-Ilan University in Israel\, her MA from the University of New Mexico\, and her BA from the Sorbonne University in Paris\, France. Dr. Ravitsky runs an active research program and holds several positions on advisory boards. Her research in bioethics focuses on ethical\, legal\, and social implications of genomics and assisted reproductive technologies\, with an emphasis on emerging biotechnologies and their implications for women’s autonomy and for disability rights. She also studies the ethics of AI in biomedicine. \nTo learn more\, visit the event webpage. \nZoom Webinar Link | Passcode: 004091
URL:https://gmkb.org/event/ethical-aspects-of-ai-in-biomedical-research-the-nih-bridge-to-ai-initiative/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240317
DTSTAMP:20260423T175443
CREATED:20231231T050844Z
LAST-MODIFIED:20231231T050844Z
UID:3804-1710201600-1710633599@gmkb.org
SUMMARY:2024 ACMG Annual Clinical Genetics Meeting
DESCRIPTION:2024 ACMG Annual Clinical Genetics Meeting \nMarch 12-16 | Toronto\, Canada \nThe ACMG sponsors an Annual Clinical Genetics Meeting and other events offering educational content in clinical genetics with the purpose of serving its members\, other healthcare professionals and the public. Experience the transformation of medical genetics as treatments can increasingly be tailored with precision medicine and therapeutics. \nTo learn more and register\, visit the meeting website. \nPlease note: Registration is required for in-person attendance and does not include session recordings. ACMG’s Digital Edition for recordings can be purchased separately and will be made available after the conference.
URL:https://gmkb.org/event/2024-acmg-annual-clinical-genetics-meeting/
LOCATION:Metro Toronto Convention Center\, 255 Front St W\, Toronto\, Ontario\, M5V 2W6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240229T090000
DTEND;TZID=America/New_York:20240229T100000
DTSTAMP:20260423T175443
CREATED:20231106T001846Z
LAST-MODIFIED:20240226T010923Z
UID:3593-1709197200-1709200800@gmkb.org
SUMMARY:Translating Science from Bench to Bedside: A Case for Extracellular Vesicles
DESCRIPTION:Translating Science from Bench to Bedside: A Case for Extracellular Vesicles \nThursday\, February 29 | 9 a.m. ET | Online \nSpeaker: Dr. Carlos Salomon Gallo \nDr. Salomon is the head of the Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group\, NHMRC Investigator Fellow and is considered a worldwide authority on extracellular vesicles (EVs) biomarkers for complications of pregnancies and ovarian cancer (OC). In the last 10 years\, Dr. Salomon’s primary research and commercialization activities have focused on the identification and validation of biomarkers\, and development of In Vitro Multivariate Index Assays for clinically relevant complications (including ovarian cancers\, and obstetrical syndromes) and their translation into clinical applications. He is a pioneer in investigating the release of EVs by the placenta and tumor cells and their utility as a biomarker for a wide range of pregnancy complications and OC. \nThis talk will cover the burgeoning field of EVs signaling holds the potential to revolutionize our understanding of cancer biology and offers new avenues for non-invasive diagnostics and therapeutic interventions. EVs have been implicated in various aspects of cancer progression\, including tumor initiation\, metastasis\, and response to therapy. From the early stages of tumor development\, tumor-derived EVs are detectable in the circulation. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar. \n 
URL:https://gmkb.org/event/translating-science-from-bench-to-bedside-a-case-for-extracellular-vesicles/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240228T120000
DTEND;TZID=America/New_York:20240228T130000
DTSTAMP:20260423T175443
CREATED:20240226T030620Z
LAST-MODIFIED:20240226T030731Z
UID:3896-1709121600-1709125200@gmkb.org
SUMMARY:Immune (check point) Related Adverse Events
DESCRIPTION:Immune (check point) Related Adverse Events \nWednesday\, February 28 | 12 p.m. ET | Online \nSpeaker: Frances Collichio\, MD\, Professor of Medicine\, UNC Chapel Hill \nDr. Collichio will review the common and uncommon side effects of immune check point inhibitors. She will also discuss the relatively new concept of delayed immune related events. \nTo learn more and register\, visit the event webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/immune-check-point-related-adverse-events/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T130000
DTEND;TZID=America/New_York:20240215T140000
DTSTAMP:20260423T175443
CREATED:20231229T052112Z
LAST-MODIFIED:20231229T052112Z
UID:3800-1708002000-1708005600@gmkb.org
SUMMARY:Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery – Current Status and the Path Forward
DESCRIPTION:Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery –\nCurrent Status and the Path Forward \nThursday\, February 15 | 1-2 p.m. ET | Virtual \nSpeakers: Paul C. Adams\, MD\, Professor\, Division of Gastroenterology\, Western University \nGail P. Jarvik\, MD\, PhD\, Head and Professor\, Division of Medical Genetics\, University of Washington \nKris V. Kowdley\, MD\, FACP\, FACG\, AGAF\, FAASLD\, Director\, Liver Institute Northwest \nIn this webinar\, speakers will discuss how knowledge about hereditary hemochromatosis (HH) has evolved since the discovery of the HFE gene in 1997\, current opportunities for clinical and public health action to prevent disease\, and future research priorities to advance case detection and reduce clinical complications from HH. \nTo learn more and register\, visit the CDC events page. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/population-screening-for-hereditary-hemochromatosis-more-than-a-quarter-century-after-gene-discovery-current-status-and-the-path-forward/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T090000
DTEND;TZID=America/New_York:20240215T100000
DTSTAMP:20260423T175443
CREATED:20240209T230341Z
LAST-MODIFIED:20240209T230341Z
UID:3874-1707987600-1707991200@gmkb.org
SUMMARY:Personalized Therapeutics: Clinical Reality and Future Challenges
DESCRIPTION:Personalized Therapeutics: Clinical Reality and Future Challenges \nThursday\, February 15 | 9 a.m. ET | Virtual \nSpeaker: George P. Patrinos \nDr. Patrinos is a professor of pharmacogenomics and pharmaceutical biotechnology in the University of Patras’ (Greece) Department of Pharmacy\, and holds adjunct professorships at Erasmus MC\, Faculty of Medicine\, Rotterdam (the Netherlands) and the United Arab Emirates University\, College of Medicine\, Department of Genetics and Genomics\, Al-Ain (UAE). He also served for 12.5 years as full member and Greece’s National Representative in the CHMP Pharmacogenomics Working Party of the European Medicines Agency (EMA) and as Chair of the Global Genomic Medicine Collaborative (G2MC) since 2018. \nAbout the Talk: This talk will provide a summary of the PREPARE and Em-HEART clinical studies in psychiatry and cardiology\, and ethical and regulatory challenges in the field of pharmacogenomics. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required.
URL:https://gmkb.org/event/personalized-therapeutics-clinical-reality-and-future-challenges/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T140000
DTEND;TZID=America/New_York:20240208T150000
DTSTAMP:20260423T175443
CREATED:20240108T025319Z
LAST-MODIFIED:20240108T025711Z
UID:3821-1707400800-1707404400@gmkb.org
SUMMARY:Duke Genomic Seminar Series
DESCRIPTION:A platform approach to develop and deploy CRISPR-Cas based experimental therapies for inborn errors of immunity in an academic/nonprofit setting \nThursday\, February 8 | 2-3 p.m. ET | Bryan Neurobiology Research Building\, Rm 103 \nSpeaker: Fyodor Urnov\, PhD\nProfessor of Molecular & Cellular Biology\, University of California\, Berkeley\nDirector of Technology & Translation\, Innovative Genomics Institute \nThe vast majority of diseases clinically tractable by genome editing using current-state technology are not the targets of active preclinical or clinical development. Addressing this issue will require more involvement of the academic/nonprofit sector\, but despite an existing charted path for advancing genome editing of specific cell types and tissues (such as T cells\, hematopoietic stem cells\, the liver\, and the retina) to the clinic\, there presently is only one open US IND for genome editing by an all-academic group. A key reason is that the current manufacturing\, regulatory\, and healthcare economics environment is not configured to maximize clinical impact of a technology like CRISPR-Cas. Under the framework that exists today\, a pediatric patient newly diagnosed with a terminal illness such as a severe inborn error of immunity due to a never-before-seen but clinically editable mutation and a life expectancy of < 1 yr will have to wait ~3.5 years until a gene editing medicine is engineered\, tested\, and manufactured at an approximate total cost of $9m. An actionable path through this status quo is to develop and clinically derisk a dedicated nonclinical development path for use in academic/nonprofit settings in N=1/rare situations of dire medical need. From a technology standpoint\, this will require comprehensive leveraging of the intrinsically platform nature of CRISPR-Cas gene editing. The Innovative Genomics Institute in close partnership with clinicians at UCSF and UCLA is developing such a platform focused on inborn errors of immunity\, where ca 112\,000 known patients suffering from 505 currently known diseases lack even a single open trial for genome editing open at the present time. \nTo learn more\, visit Duke’s Genomic Seminar Series page. \nPlease note: This seminar series occurs quarterly with some events occurring virtually only and others in-person with streaming options.
URL:https://gmkb.org/event/duke-genomic-seminar-series/
LOCATION:Duke Neurobiology Research Center\, 311 Research Drive\, Durham\, NC\, 27710\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240111T150000
DTEND;TZID=America/New_York:20240111T160000
DTSTAMP:20260423T175443
CREATED:20231231T032420Z
LAST-MODIFIED:20231231T032420Z
UID:3802-1704985200-1704988800@gmkb.org
SUMMARY:Global Diversity\, Local Context: The Role of Ancestry\, Genetics\, and Environment on Human Health
DESCRIPTION:Global Diversity\, Local Context: The Role of Ancestry\, Genetics\, and Environment on Human Health \nThursday\, January 11 | 3-4 p.m. ET | In-person & Virtual \nSpeaker: Genevieve Wojcik\, PhD\, MHS\nGenetic Epidemiologist and Assistant Professor of Epidemiology\nJohns Hopkins Bloomberg School of Public Health \nDr. Wojcik’s research focuses on understanding the role of ancestry in genetic risk and developing solutions to address health inequities for diverse and admixed populations\, as well as genetic susceptibility to infectious disease. Her most recent work explores the interaction of genetic ancestry and environment in admixed populations and downstream consequences for genetic risk prediction. Dr. Wojcik is a member of multiple NIH consortia\, including the Population Architecture using Genomics and Epidemiology (PAGE) Study\, the Clinical Genome Resource (ClinGen)\, and the Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium. \nThe Genomics and Health Disparities Lecture Series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics will range from basic science to translational research. \nTo learn more and register\, visit the lecture series page. \nPlease note: Zoom registration is required for virtual attendees.
URL:https://gmkb.org/event/global-diversity-local-context-the-role-of-ancestry-genetics-and-environment-on-human-health/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240104T120000
DTEND;TZID=America/New_York:20240104T130000
DTSTAMP:20260423T175443
CREATED:20231219T032932Z
LAST-MODIFIED:20231219T032932Z
UID:3770-1704369600-1704373200@gmkb.org
SUMMARY:An Overview of Applied Machine Learning in Medicine at UNC
DESCRIPTION:An Overview of Applied Machine Learning in Medicine at UNC \nThursday\, January 4 | 12-1 p.m. ET | 4th Floor Old Clinic Auditorium or Online \nSpeaker: Amanda Nelson\, MD\nAssociate Professor of Medicine\, UNC-Chapel Hill \nA discussion on the application of AI tools to answer clinical questions around diagnosis\, phenotyping\, prognosis\, and precision medicine using examples from investigators at UNC. \n  \nWebEx Information: \nhttps://uncsom.webex.com/uncsom/j.php?MTID=m893f54367d9d2ac90bbac612e815bf88\nMeeting number (access code): 2314 463 7243\nMeeting password: V!rtu@lmgr22
URL:https://gmkb.org/event/an-overview-of-applied-machine-learning-in-medicine-at-unc/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231221T090000
DTEND;TZID=America/New_York:20231221T100000
DTSTAMP:20260423T175443
CREATED:20231219T032454Z
LAST-MODIFIED:20231219T032454Z
UID:3767-1703149200-1703152800@gmkb.org
SUMMARY:Personalized Risk Assessment for Early Detection of Cancer
DESCRIPTION:Personalized Risk Assessment for Early Detection of Cancer \nThursday\, December 21 | 9 a.m. ET | Online \nSpeaker: Dr. Nora Pashayan \nDr. Pashayan is a Professor of the Epidemiology of Aging and honorary Consultant in Public Health Medicine at the University of Cambridge.  She is a cancer epidemiologist\, a clinician with specialties in both Family Medicine and Public Health Medicine\, and the Director of Training for the International Alliance for Cancer Early Detection. Dr. Pashayan’s primary research field is cancer early detection\, risk stratification\, and population-level screening.  Her research focuses on understanding disease courses\, evaluating screening strategies\, and implementation of novel screening strategies. \nThis talk will introduce the concept of risk-stratified cancer screening and explore the essential considerations for implementation of such a screening program. Examples on integration and implementation will be drawn from the ongoing Canadian study\, PERSPECTIVE I&I. \nTo learn more and register\, visit the GGMC Educational Webinar Series page. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/personalized-risk-assessment-for-early-detection-of-cancer/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231214T140000
DTEND;TZID=America/New_York:20231214T150000
DTSTAMP:20260423T175443
CREATED:20230920T160637Z
LAST-MODIFIED:20230920T160637Z
UID:3494-1702562400-1702566000@gmkb.org
SUMMARY:NHGRI Division of Intramural Research Seminar
DESCRIPTION:Thursday\, December 14 | 2 – 3 p.m. | Bethesda\, MD & Online \nThe Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience. \nAll seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available. \nSpeaker:\nMarius Wernig\, M.D.\, Ph.D.\nProfessor in the Departments of Pathology and Chemical and Systems Biology\nStanford University School of Medicine \nHosts: William Gahl\, May Christine Malicdan and Marie Morimoto \n\nView past presentations\, learn more about upcoming seminars\, and register to attend on the NHGRI website.
URL:https://gmkb.org/event/nhgri-division-of-intramural-research-seminar-4/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231206T160000
DTEND;TZID=America/New_York:20231206T171500
DTSTAMP:20260423T175443
CREATED:20231129T162532Z
LAST-MODIFIED:20231129T162532Z
UID:3618-1701878400-1701882900@gmkb.org
SUMMARY:Carolina Seminar Series | Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science
DESCRIPTION:Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science \nWednesday\, December 6 | 4 p.m. ET | Online \nSpeakers: Caitlin Allen\, PhD\, MPH\nAssistant Professor\, Medical University of South Carolina \nElizabeth Mayer-Davis\, PhD\, RD\nBoshamer Distinguished Professor of Nutrition and Medicine\, UNC-Chapel Hill \nAs technologies and health interventions expand at a rapid rate in healthcare\, many providers and patients desire quick and efficient incorporation of these new offerings in to practice.  The field of implementation science can be critical in studying the barriers and facilitators to bring options previously available only in the research realm to the clinic. The design and development of health interventions are increasingly informed by implementation science theories\, models\, and frameworks to emphasize diverse reach and improve adoption and increase health equity in under served and marginalized communities. By testing new clinical offerings with implementation science methodologies\, we can improve the quality of health practices for all patients while promoting equity and inclusion and ensuring that the availability of novel clinical offerings does not exacerbate existing health disparities. \nTo learn more and register\, visit the UNC events page. \nPlease note: Registration is required for this seminar.
URL:https://gmkb.org/event/carolina-seminar-series-precision-medicine-research-and-novel-clinical-offerings-ensuring-equitable-impact-through-implementation-science/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231130T120000
DTEND;TZID=America/New_York:20231130T130000
DTSTAMP:20260423T175443
CREATED:20230831T124810Z
LAST-MODIFIED:20230831T124810Z
UID:3488-1701345600-1701349200@gmkb.org
SUMMARY:Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation
DESCRIPTION:Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation \nThursday\, November 30 | 12-1 p.m. ET | Online \nSpeakers: Dr. Stephen F. Kingsmore\, president/CEO of Rady Children’s Institute for Genomic Medicine (RCIGM) \nTo learn more and register\, visit the CDC event page. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/rapid-genome-sequencing-for-diagnosing-critically-ill-infants-and-children/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T120000
DTEND;TZID=America/New_York:20231115T131500
DTSTAMP:20260423T175443
CREATED:20231029T194313Z
LAST-MODIFIED:20231029T194633Z
UID:3573-1700049600-1700054100@gmkb.org
SUMMARY:NASEM | Roundtable on Genomics and Precision Health - Strategic Plan Reflection on the Roundtable's Work Since 2020
DESCRIPTION:Roundtable on Genomics and Precision Health – Strategic Plan Reflection on the Roundtable’s Work Since 2020 \nWednesday\, November 15 | 12 p.m. ET | Online \nThe Roundtable on Genomics and Precision Health will host a virtual event to highlight the work of the Roundtable since the adoption of its strategic plan in 2020. Speakers will provide their perspectives on the goals and key takeaways heard from workshop and event speakers as well as look ahead to what comes next. Public events include: \n\nImproving Diversity of the Genomics Workforce: A Workshop (2021)\nViews & Voices: Reporting Genetics and Genomics (2022)\nRealizing the Potential of Genomics across the Continuum of Precision Health Care: A Workshop (2022)\nNext-Generation Screening – The Promise and Perils of DNA Sequencing of Newborns at Birth: A Workshop (2023)\n\nThe event will be accessible via webinar. Learn more and register on the event page.
URL:https://gmkb.org/event/nasem-roundtable-on-genomics-and-precision-health-strategic-plan-reflection-on-the-roundtables-work-since-2020/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231110T110000
DTEND;TZID=America/New_York:20231110T120000
DTSTAMP:20260423T175443
CREATED:20231106T194601Z
LAST-MODIFIED:20231106T194742Z
UID:3603-1699614000-1699617600@gmkb.org
SUMMARY:Precision Medicine and Immunotherapy: The new frontiers in cancer care?
DESCRIPTION:Precision Medicine and Immunotherapy: The new frontiers in cancer care? \nFriday\, November 10 | 11 a.m. ET | Online \nSpeaker: Ugwuji Maduekwe\, MD\, MMSc\, MPH \nDr. Maduekwe will present an exploration of the dispersion of new therapies in the care of cancer that are inequitably distributed and solutions to closing these gaps. \nTo learn more and register\, visit the webinar page. \nPlease note: Registration for the full webinar series is required.
URL:https://gmkb.org/event/precision-medicine-and-immunotherapy-the-new-frontiers-in-cancer-care/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231109T100000
DTEND;TZID=America/New_York:20231109T173000
DTSTAMP:20260423T175443
CREATED:20231101T203816Z
LAST-MODIFIED:20231101T203816Z
UID:3590-1699524000-1699551000@gmkb.org
SUMMARY:Transdisciplinary Conference for Future Leaders in Precision Public Health
DESCRIPTION:Transdisciplinary Conference for Future Leaders in Precision Public Health \nThursday\, November 9 | 10 a.m. ET | Online \nThe UNC Eshelman School of Pharmacy’s Precision Public Health Network is sponsoring this free\, virtual conference with expert speakers\, a breakout networking session\, and a virtual poster session. A follow-up workshop will be held on Thursday\, November 16\, from 3-6 p.m. ET to discuss priority-setting for the field. \nFor more information and to register\, visit the event page. \nPlease note: Registration is required.
URL:https://gmkb.org/event/transdisciplinary-conference-for-future-leaders-in-precision-public-health/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231108T160000
DTEND;TZID=America/New_York:20231108T171500
DTSTAMP:20260423T175443
CREATED:20231022T235958Z
LAST-MODIFIED:20231023T002204Z
UID:3558-1699459200-1699463700@gmkb.org
SUMMARY:Carolina Seminar Series | Empowering Trust: Insights from Community Engagement Initiatives
DESCRIPTION:Empowering Trust: Insights from Community Engagement Initiatives \nWednesday\, November 8 | 4 p.m. ET | Online \nSpeaker: Mya Roberson\, MSPH\, PhD\,\nAssistant Professor\, Department of Health Policy and Management\, UNC-Chapel Hill \nCommunity engagement continues to be a critical component in genomic medicine and precision health research where the overall goal is to improve health outcomes of communities.  The translation of findings into practice and implementation depends heavily on stakeholder engagement throughout the research process. This seminar session will explore insights gained from various engagement strategies and how appropriate incorporation of community stakeholders’ insights can improve the relevance and usefulness of genomic medicine and precision health research.  Speakers and panelists will share their perspectives on community engagement\, discuss strategies to address the gaps that remain and how to address the challenge of hesitancy among some communities. \nTo learn more and register\, visit the UNC events page. \nPlease note: Registration is required for this seminar.
URL:https://gmkb.org/event/carolina-seminar-series-empowering-trust-insights-from-community-engagement-initiatives/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231101
DTEND;VALUE=DATE:20231106
DTSTAMP:20260423T175443
CREATED:20221202T182935Z
LAST-MODIFIED:20221202T182935Z
UID:2888-1698796800-1699228799@gmkb.org
SUMMARY:ASHG Annual Meeting
DESCRIPTION:November 1-5 | Washington\, DC \nThe American Society for Human Genetics (ASHG) annual meeting will take place November 1-5\, 2023\, in Washington\, D.C. \nVisit the meeting website for more information.
URL:https://gmkb.org/event/ashg-annual-meeting-2/
LOCATION:Walter E. Washington Convention Center
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231031T130000
DTEND;TZID=America/New_York:20231031T140000
DTSTAMP:20260423T175443
CREATED:20231029T203025Z
LAST-MODIFIED:20231029T205222Z
UID:3580-1698757200-1698760800@gmkb.org
SUMMARY:FDA Webinar | Proposed Rule: Medical Devices; Laboratory Developed Tests
DESCRIPTION:Proposed Rule: Medical Devices; Laboratory Developed Tests \nTuesday\, October 31 | 1 p.m. ET | Online \nThe U.S. Food and Drug Administration (FDA) will host a public webinar to provide information on the proposed rule regarding Laboratory Developed Tests (LDTs). During the webinar\, the FDA will: \n\nProvide an overview of the rulemaking proposal to amend the FDA’s regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food\, Drug\, and Cosmetic Act including when the manufacturer of the IVD is a laboratory.\nDescribe the proposed phaseout of FDA’s general enforcement discretion approach to LDTs.\nHost a Q&A session based on questions that have been submitted prior to the webinar at CDRHWebinars@fda.hhs.gov. Questions will not be taken during the live webinar. All questions are due by October 23\, 2023\, to be considered for the discussion.\n\nRegistration is not required. To learn more and access the Zoom webinar details\, visit the event page.
URL:https://gmkb.org/event/fda-webinar-proposed-rule-medical-devices-laboratory-developed-tests/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231030T140000
DTEND;TZID=America/New_York:20231030T150000
DTSTAMP:20260423T175443
CREATED:20230920T160159Z
LAST-MODIFIED:20230920T160159Z
UID:3492-1698674400-1698678000@gmkb.org
SUMMARY:NHGRI Division of Intramural Research Seminar
DESCRIPTION:Monday\, October 30 | 2 – 3 p.m. | Bethesda\, MD & Online \nThe Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience. \nAll seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available. \nSpeaker:\nMatthew Hurles\, FMedSci\, FRS\nDirector\, Wellcome Sanger Institute \nCo-Host:\nEric Green\, NHGRI Office of the Director \nView past presentations\, learn more about upcoming seminars\, and register to attend on the NHGRI website.
URL:https://gmkb.org/event/nhgri-division-of-intramural-research-seminar-3/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231026T110000
DTEND;TZID=America/New_York:20231026T120000
DTSTAMP:20260423T175443
CREATED:20230719T131639Z
LAST-MODIFIED:20230719T131639Z
UID:3449-1698318000-1698321600@gmkb.org
SUMMARY:Cost-Effectiveness Analysis in Public Health Genomics & Precision Health
DESCRIPTION:Thursday\, October 26 | 11 a.m. – 12 p.m. ET | Online \n\nCDC Webinar – Cost-Effectiveness Analysis in Public Health Genomics and Precision Health: Recent Findings\, Methodologic Issues\, and the Path Forward \nSpeaker:\nDavid Veenstra\, PhD\nProfessor in the Department of Pharmacy and the Comparative Health Outcomes\, Policy & Economics (CHOICE) Institute\nUniversity of Washington \nPlease note: registration is required. Visit the CDC Genomics & Precision Health event page to learn more and sign up.
URL:https://gmkb.org/event/cost-effectiveness-analysis-in-public-health-genomics-precision-health/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231026T070000
DTEND;TZID=America/New_York:20231026T080000
DTSTAMP:20260423T175443
CREATED:20231016T155047Z
LAST-MODIFIED:20231016T155047Z
UID:3552-1698303600-1698307200@gmkb.org
SUMMARY:Challenges\, Insights and Outcomes of a Clinically Integrated Multi-omic Rare Disease Program
DESCRIPTION:Challenges\, Insights and Outcomes of a Clinically Integrated Multi-omic Rare Disease Program\, RDNow\, for Individuals Who Remain Undiagnosed After Clinical Genomic Sequencing \nThursday\, October 26 | 7 a.m. ET | Online \nSpeaker: Dr. Michelle de Silva \nMichelle is an associate genetic counselor with a PhD in molecular genetics. She is an experienced medical researcher and has managed several multidisciplinary research centres at the University of Melbourne\, while also working as the program manager of the Rare Disease Flagship and RDNow Program at Murdoch Children’s Research Institute in Melbourne. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/challenges-insights-and-outcomes-of-a-clinically-integrated-multi-omic-rare-disease-program/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231018T150000
DTEND;TZID=America/New_York:20231018T161500
DTSTAMP:20260423T175443
CREATED:20231012T144405Z
LAST-MODIFIED:20231012T144703Z
UID:3521-1697641200-1697645700@gmkb.org
SUMMARY:PRS for the PCP: Evaluating polygenic risk scoring in primary care with clinical trials
DESCRIPTION:Wednesday\, October 18 | 3 – 4:15 p.m. ET | Online\n \nBeginning September 2022\, NHGRI will host a new seminar series based on its Genomic Innovator Award Program\, which supports innovative work by early-career genomics investigators who are part of consortia or other team-science efforts. Each seminar will feature an early-career researcher and an established researcher. Their presentations will cover specific topics that showcase the creative ways that early-career investigators are accelerating genomics research. \nEach seminar will include two speakers (each giving 20-minute talks) followed by a moderated Q&A session. \nThis seminar will be presented by speakers: \nKatrina A.B. Goddard\, Ph.D.\nDirector\, Division of Cancer Control and Population Sciences\nNational Cancer Institute \nJason L. Vassy\, M.D.\, MPH\, M.S.\nAssociate Professor of Medicine; Clinician-Investigator; Founding Member of Precision Population Health\nHarvard Medical School; Veterans Affairs (VA) Boston Healthcare System and Brigham and Women’s Hospital; Ariadne Labs \nPlease note: registration is required. Learn more and register on the Genomic Innovator Seminar Series website.
URL:https://gmkb.org/event/3521/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231004T150000
DTEND;TZID=America/New_York:20231004T170000
DTSTAMP:20260423T175443
CREATED:20230920T171413Z
LAST-MODIFIED:20230920T171424Z
UID:3497-1696431600-1696438800@gmkb.org
SUMMARY:Cystic Fibrosis: Precision Treatment of a Rare Monogenic Disease
DESCRIPTION:Wednesday\, October 4 | 3 – 5 p.m. ET | Online \nJoin the UNC Program for Precision Medicine in Healthcare (PPMH) for Cystic Fibrosis: Precision Treatment of a Rare Monogenic Disease\, a free virtual mini-symposium. At this interactive event\, participants will engage in discussion with leading precision nutrition researchers at UNC. \nPresentation: Developing small-molecule therapies to rescue rare CFTR variants\nSpeaker:\nRhianna Lee\, PhD\nPostdoctoral associate\, Duke University\, Cell Biology Department \nPresentation: Personalized medicine\, the fight against antibiotic resistance\, and precision dosing\nSpeaker:\nGauri Rao\, PharmD\nAssociate Professor\, USC Mann School of Pharmacy and Pharmaceutical Sciences\, University of Southern California\nAdjunct Associate Professor\, UNC Eshelman School of Pharmacy\, UNC Chapel Hill \nPresentation: From Data to Dosing: Streamlining CF Modulator Choices\nSpeaker:\nMichael Adams\, MD\nClinical Instructor\, Division of Genetics & Metabolism\, Department of Pediatrics\, UNC School of Medicine \nLearn more and register on the PPMH website.
URL:https://gmkb.org/event/cystic-fibrosis-precision-treatment-of-a-rare-monogenic-disease/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231002
DTEND;VALUE=DATE:20231005
DTSTAMP:20260423T175443
CREATED:20221202T182353Z
LAST-MODIFIED:20221202T182353Z
UID:2885-1696204800-1696463999@gmkb.org
SUMMARY:G2MC 7th International Conference
DESCRIPTION:October 2-4\, 2023 | Online & Geneva\, Switzerland \nThe Global Genomic Medicine Consortium (G2MC) 7th International Conference will be held October 2-4\, 2023 in Geneva\, Switzerland. For those unable to attend in person\, we will also be incorporating virtual sessions. \nThe theme of the 2023 conference is connecting with governing bodies and organizations\, particularly LMICs\, to enhance collaborations to ultimately influence genomic medicine implementation worldwide. \nVisit the conference website for more information.
URL:https://gmkb.org/event/g2mc-7th-international-conference/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230928T110000
DTEND;TZID=America/New_York:20230928T170000
DTSTAMP:20260423T175443
CREATED:20230831T124015Z
LAST-MODIFIED:20230831T124015Z
UID:3485-1695898800-1695920400@gmkb.org
SUMMARY:Exploring the Evolution of Familial Disease to Today’s Possibility for Hereditary Cancer Prevention
DESCRIPTION:From Generations Past to Future Health: Exploring the Evolution of Familial Disease to Today’s Possibility for Hereditary Cancer Prevention \nThursday\, September 28 | 11 a.m. ET | Online \nSpeakers: Dr. Oscar Lao\, Principal Investigator at Institut de Biologia Evolutiva\, and Dr. Brian Shirts\, Associate Professor of Laboratory Medicine and Pathology\, University of Washington \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/exploring-the-evolution-of-familial-disease-to-todays-possibility-for-hereditary-cancer-prevention/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230921T140000
DTEND;TZID=America/New_York:20230921T150000
DTSTAMP:20260423T175443
CREATED:20230719T130500Z
LAST-MODIFIED:20230920T160713Z
UID:3447-1695304800-1695308400@gmkb.org
SUMMARY:NHGRI Division of Intramural Research Seminar
DESCRIPTION:Thursday\, September 21 | 2 – 3 p.m. | Bethesda\, MD & Online \nThe Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience. \nAll seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available. \nSpeaker:\nBrittany Adamson\, Ph.D.\nAssistant Professor\, Department of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics\nPrinceton University \nHosts: Meru Sadhu and Annette Iturralde Guerrero \n\nView past presentations\, learn more about upcoming seminars\, and register to attend on the NHGRI website.
URL:https://gmkb.org/event/nhgri-division-of-intramural-research-seminar-2/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230914T120000
DTEND;TZID=America/New_York:20230914T130000
DTSTAMP:20260423T175443
CREATED:20230421T144112Z
LAST-MODIFIED:20230421T144112Z
UID:3263-1694692800-1694696400@gmkb.org
SUMMARY:The Promise and Challenges of Implementing Pharmacogenomics to Improve Population Health
DESCRIPTION:Thursday\, September 14 | 12-1 p.m. ET | Online \nCDC Webinar: The Promise and Challenges of Implementing Pharmacogenomics to Improve Population Health: Where Are we Heading with Preemptive Pharmacogenomic Screening? \nIndividual variability in drug response efficacy or safety is becoming an increasing problem globally\, given the growing population of older adults. Reasons for this variability include genomic factors\, an area of study called pharmacogenomics. With genotyping technologies now widely available and decreasing in cost\, implementing pharmacogenomics into clinical practice is widely viewed as an initial step in mainstreaming genomic medicine. \nThis seminar will review recent developments in the field of pharmacogenomics and the ongoing challenges in equitable translation of discoveries into clinical practice and public health programs. \nSpeaker: \nProfessor Sir Munir Pirmohamed\, MB ChB (Hons)\, PhD\, FRCP\, FRCP(E)\, FFPM\, FRSB\, FBPhS\, FMedSci\nDavid Weatherall Chair of Medicine and National Health Service Chair of Pharmacogenetics\nDirector\, Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine\nInstitute of Systems\, Molecular and Integrative Biology (ISMIB)\nUniversity of Liverpool \nPlease note: registration is required. Visit the CDC Genomics & Precision Health event page to learn more and sign up.
URL:https://gmkb.org/event/the-promise-and-challenges-of-implementing-pharmacogenomics-to-improve-population-health/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230907
DTEND;VALUE=DATE:20230909
DTSTAMP:20260423T175443
CREATED:20230818T160915Z
LAST-MODIFIED:20230818T160915Z
UID:3475-1694044800-1694217599@gmkb.org
SUMMARY:Training in Genomics & Precision Public Health
DESCRIPTION:Thursday-Friday\, September 7-8 | Online \nAdvances in genomics\, data science\, machine learning\, and artificial intelligence are transforming practice. Next generation public health and medical workforces need to understand these developments and how they can be used to benefit population health. \nRecognizing this challenge\, Oak Ridge Institute for Science and Education (ORISE) is partnering with the Office of Genomics and Precision Public Health at the Centers for Disease Control and Prevention (CDC) to offer a free 2-day training event covering the latest developments in these fields: Current Issues in Genomics and Precision Public Health – Using Genomics and Big Data to Improve Population Health and Reduce Health Inequities.   \nLearn more and register on the event website.
URL:https://gmkb.org/event/training-in-genomics-precision-public-health/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR